Meihua International Medical Te MHUA

Competitive advantage analysis · healthcare

Medical Devices & Diagnostics
Overall moat score
62/100
Moderate

Ranked against 61 peers in Medical Instruments & Supplies

Key strengths

  • Strong FCF Generation FCF margin quality is top-tier vs peers (score 0.78). High FCF conversion confirms strong earnings quality.
  • Superior Capital Returns Capital return quality is top-tier (score 0.71). High ROIC indicates the business is reinvesting at attractive rates.

Key risks

  • Below-Peer Gross Margins Gross margin quality lags peers (score 0.28). May indicate commodity-like product mix or distributor margin drag.
  • Declining Capital Returns ROIC durability is weak (score 0.00). Volatility or decline in returns is a leading moat erosion signal.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Developing
33
Premium

Signals, strengths and risks for Pricing Power & Consumable Moat

Premium

Signals, strengths and risks for R&D Pipeline & Capital Returns

Premium

Signals, strengths and risks for FCF Quality & Cash Conversion

Premium

Signals, strengths and risks for Commercial Execution

Premium

Signals, strengths and risks for Capital Structure & Resilience

Premium

Signals, strengths and risks for Growth Durability

Where MHUA ranks in Medical Instruments & Supplies

Meihua International Medical Te ranks #19 of 62 scored companies in Medical Instruments & Supplies by moat score — the top 31%. The widest moat in the group is Intuitive Surgical, Inc. (ISRG) at 86/100.

# Company Moat score Rating
15 Haemonetics Corporation HAE 64/100 Moderate
16 West Pharmaceutical Services, I WST 64/100 Moderate
17 Becton, Dickinson and Company BDX 63/100 Moderate
18 Stevanato Group S.p.A. STVN 63/100 Moderate
19 Meihua International Medical Te MHUA 62/100 Moderate
20 Nephros, Inc. NEPH 62/100 Moderate
21 Bausch + Lomb Corporation BLCO 61/100 Moderate
22 Azenta, Inc. AZTA 61/100 Moderate
23 Envista Holdings Corporation NVST 60/100 Moderate

See every Medical Devices & Diagnostics company ranked by moat score →

How MHUA scores on the Medical Devices & Diagnostics defenses

Pricing Power & Consumable Moat

Score 33 · 25% of the moat score

In MedTech, pricing power is rarely about the machine — it is about what the machine consumes.

R&D Pipeline & Capital Returns

Score 71 · 20% of the moat score

Research spending is how a device company keeps its installed base current, but spending alone proves nothing.

FCF Quality & Cash Conversion

Score 78 · 20% of the moat score

MedTech companies grow by acquisition, and the resulting intangible amortisation depresses reported earnings without consuming any cash.

Commercial Execution

Score 72 · 15% of the moat score

Devices are sold into hospitals and labs through committees, tenders and long qualification cycles, which makes the sales organisation expensive and hard to replicate.

Capital Structure & Resilience

Score 71 · 12% of the moat score

Serial acquirers carry debt, and the question is whether the cash flows underneath it are dependable enough to service it through a downturn.

Growth Durability

Score 64 · 8% of the moat score

Growth durability separates an expanding installed base from a good product cycle.

How each Medical Devices & Diagnostics defense is measured, in full →

Understanding MHUA's moat

What is Meihua International Medical Te's moat score?

Meihua International Medical Te (MHUA) scores 62 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as moderate. It ranks #19 of 62 scored companies in Medical Instruments & Supplies, the top 31%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 61 companies in Medical Instruments & Supplies. Its strongest defense is FCF Quality & Cash Conversion (78/100) and its weakest is Pricing Power & Consumable Moat (33/100).

How does Meihua International Medical Te compare with other Medical Instruments & Supplies companies?

Meihua International Medical Te ranks #19 of 62 scored companies in Medical Instruments & Supplies by moat score. The widest moat in Medical Instruments & Supplies is Intuitive Surgical, Inc. (ISRG) at 86/100. The companies ranked closest are Stevanato Group S.p.A. (STVN) at 63 just above it and Nephros, Inc. (NEPH) at 62 just below it.

How is the moat score calculated?

Each company is scored with an industry-specific template — Medical Devices & Diagnostics in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 61 companies in Medical Instruments & Supplies. The defenses are then weighted to produce the overall score out of 100.

Why is Meihua International Medical Te scored with the Medical Devices & Diagnostics template?

Medical device and diagnostics companies place an instrument once and then sell the consumables, reagents and service that instrument needs for the next decade. The economics are a razor-and-blade model wrapped in regulatory approval and clinician habit, so the MedTech template scores the durability of that installed base rather than the size of any single product launch.

Which competitive defenses are measured for Meihua International Medical Te?

The Medical Devices & Diagnostics template measures 6 defenses, and MHUA scores: Pricing Power & Consumable Moat (33), R&D Pipeline & Capital Returns (71), FCF Quality & Cash Conversion (78), Commercial Execution (72), Capital Structure & Resilience (71), Growth Durability (64). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.

Send Feedback
Please select a category.
0/1000